dc.contributor.author | Dikmen, Pınar Yalınay | |
dc.contributor.author | Baykan, Betül | |
dc.contributor.author | Uludüz, Derya | |
dc.contributor.author | Özge, Aynur | |
dc.contributor.author | Aydınlar, Elif Ilgaz | |
dc.contributor.author | Polat, Burcu | |
dc.contributor.author | Karlı, Necdet | |
dc.contributor.author | Tepe, Nermin | |
dc.date.accessioned | 2024-08-27T06:20:23Z | |
dc.date.available | 2024-08-27T06:20:23Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.issn | 0333-1024 / 1468-2982 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12462/15061 | |
dc.description | Tepe, Nermin (Balikesir Author) | en_US |
dc.description.abstract | Özet bilgisi yok. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Sage Publications Ltd | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurosciences & Neurology | en_US |
dc.title | Real-life experiences with galcanezumab disclosed new predictors for response | en_US |
dc.type | other | en_US |
dc.relation.journal | Cephalalgia | en_US |
dc.contributor.department | Tıp Fakültesi | en_US |
dc.identifier.volume | 43 | en_US |
dc.identifier.issue | Supplement 1 | en_US |
dc.identifier.startpage | 244 | en_US |
dc.identifier.endpage | 245 | en_US |
dc.relation.publicationcategory | Diğer | en_US |